Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - methyl-
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
High Concentration Methylcobalamin (Me-Cbl) or Combination of
Methyl-
and Hydroxocobalamin (Me/OH-Cbl) for the Treatment of Cobalamin C Deficiency and Related Disorders
Cobalamin C deficiency (cblC), caused by mutations in MMACHC, is the most common inborn error of intracellular vitamin B12 metabolism. NHGRI scientist have generated a number of Mmachc knockout mouse models. The cblC mice present with early lethality, recapitulate the neurological phenotype seen in patients, and have enabled proof of concept testing...
Published: 10/28/2024
|
Inventor(s):
Jennifer Sloan
,
Eirini (Irini) Manoli
,
Charles Venditti
Keywords(s):
C
,
Cobalamin
,
Combination
,
Concentration
,
DEFICIENCY
,
DISORDERS
,
High
,
Hydroxocobalamin
,
Me/OH-Cbl
,
Me-Cbl
,
Methyl-
,
Methylcobalamin
,
RELATED
,
treatment
,
VPXXXX
,
WKXXXX
Category(s):
Application > Therapeutics
,
TherapeuticArea > Cardiology
,
TherapeuticArea > Infectious Disease
,
TherapeuticArea > Ophthalmology
,
TherapeuticArea > Oncology
,
TherapeuticArea > Endocrinology
,
TherapeuticArea > Dental
Aberrant Post-translational Modifications (PTMs) in
Methyl-
and Propionic Acidemia and the Construction of a Novel Sirtuin (SIRT) Gene to Metabolize PTMs
Isolated Methylmalonic Acidemia (MMA) and the related disorder Propionic Acidemia (PA) comprise a relatively common and heterogeneous group of inborn errors of metabolism. NHGRI scientist discovered that in isolated MMA, a novel inhibitory PTM, methylmalonyllysine, is generated and inactivates protein targets through the failure of SIRT-mediated deacylation,...
Published: 10/28/2024
|
Inventor(s):
PamelaSara Head
,
Charles Venditti
Keywords(s):
Aberrant
,
Acidemia
,
Construction
,
Discovery
,
Ene
,
Metabolize
,
Methyl-
,
Modifications
,
Novel
,
Post-translational
,
Propionic
,
PTMs
,
Sirt
,
Sirtuin
,
VPXXXX
,
WIXXXX
,
WKXXXX
,
XEXXXX
Category(s):
TherapeuticArea > Endocrinology
,
TherapeuticArea > Dental
,
TherapeuticArea > Oncology
,
TherapeuticArea > Cardiology
,
TherapeuticArea > Ophthalmology
,
Application > Therapeutics
,
TherapeuticArea > Infectious Disease
,
Application > Research Materials